|
ADAM9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.883800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.902100E-02 |
| Normal-vs-Stage2 |
1.770610E-01 |
| Normal-vs-Stage3 |
1.744850E-03 |
| Normal-vs-Stage4 |
3.820100E-04 |
| Stage1-vs-Stage2 |
8.817600E-01 |
| Stage1-vs-Stage3 |
6.217500E-02 |
| Stage1-vs-Stage4 |
1.668010E-02 |
| Stage2-vs-Stage3 |
3.543200E-01 |
| Stage2-vs-Stage4 |
1.477800E-01 |
| Stage3-vs-Stage4 |
4.037000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.804600E-03 |
| Normal-vs-AfricanAmerican |
1.465770E-01 |
| Normal-vs-Asian |
1.184550E-01 |
| Caucasian-vs-AfricanAmerican |
8.374400E-01 |
| Caucasian-vs-Asian |
7.035000E-01 |
| AfricanAmerican-vs-Asian |
9.365800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.055900E-03 |
| Normal-vs-Female |
1.420310E-02 |
| Male-vs-Female |
2.876400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.556600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.757790E-03 |
| Normal-vs-Age(61-80Yrs) |
3.800300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.032000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.777810E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.514300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.235600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.244800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.023000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.420600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.074800E-01 |
| Classical-VS-Follicular |
4.557600E-01 |
| Classical-VS-Other |
5.833600E-01 |
| Classical-VS-Normal |
3.354100E-02 |
| Tall-VS-Follicular |
6.180800E-01 |
| Tall-VS-Other |
4.166800E-01 |
| Tall-VS-Normal |
1.435910E-02 |
| Follicular-VS-Other |
4.981800E-01 |
| Follicular-VS-Normal |
2.900300E-02 |
| Other-VS-Normal |
8.948800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.603600E-03 |
| Normal-vs-N1 |
3.964600E-03 |
| N0-vs-N1 |
4.951600E-01 |
|
|
